BioMe Inc.
PrivateLast Round
Series A
Dec 3, 2024
Total Funding Raised
$2.11M
Company Overview
BioMe Inc. operates in Healthcare & Life Sciences and is based in Seoul. Its latest recorded funding round was a Series A round in December 2024.
BioMe Inc. is a biotechnology company that develops microbiome-based live biotherapeutic products (LBPs) for the treatment of chronic and intractable diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Healthcare Analytics, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioMe Inc. Comparables
Compare BioMe Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CJ Bioscience Inc. | 76% | |
| HEM Pharma Inc. | 73% | |
| Tiny Health | 71% |
For institutional investors. Book with your work email.
BioMe Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 3, 2024 | ||||
| Pre Seed | Oct 5, 2021 |
For institutional investors. Book with your work email.
BioMe Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ScaleUp Partners | Series A, Pre Seed |
| Celltrion | Series A |
| Mirae Asset Venture Investment | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 3, 2024
$2.1M round led by Celltrion
- Oct 5, 2021
Mirae Asset Venture Investment led the round.
For institutional investors. Book with your work email.
BioMe Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about BioMe Inc.'s valuation, stock price, and market status.
Is BioMe Inc. a public or private company?
BioMe Inc. is a private company.
What is the current stock price of BioMe Inc.?
BioMe Inc. is a private company, so its shares have no public market price. Caplight tracks BioMe Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BioMe Inc. worth (valuation)?
Valuation information for BioMe Inc. is not publicly available.
Can I buy BioMe Inc. stock?
BioMe Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BioMe Inc.'s last funding round?
BioMe Inc.'s most recent funding round was Series A on December 3, 2024.
Who are the main investors in BioMe Inc.?
Key investors in BioMe Inc. include Celltrion, Mirae Asset Venture Investment.
Will BioMe Inc. IPO soon?
No public IPO plans have been announced for BioMe Inc..
How can I track BioMe Inc. secondary market activity?
Caplight tracks bids, offers, and trades in BioMe Inc.'s shares on secondary markets.